Search
Search Results
##search.searchResults.foundPlural##
-
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3416PDF: 2323HTML: 1401 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
8810PDF: 5925HTML: 87435Fig.1b: 159Fig.1c: 164Fig.2a: 154Fig.2b: 154Fig.4: 167Fig.2c: 152Fig.3: 160Tab.1: 208Tab.2: 186Tab.3: 175Tab.4: 194Fig1a: 151 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2733PDF: 1180HTML: 2663Figure 1: 142 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3289PDF: 1239HTML: 2187Fi.1 Gritti.Rambaldi: 181 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3103PDF: 741HTML: 2909Figure 1a and 1b: 132Figure 2: 135Figure 3: 157Figure 4: 141Figure 5: 143Tables 1-5: 139 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
3933PDF: 1883HTML: 5188Table 1: 165 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4222PDF: 1444HTML: 1528Untitled: 207 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2176PDF: 1285HTML: 17047Bassan Fig.1: 133Bassan Fig.2: 129Bassan Fig.4: 124Fig.3: 161 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3663PDF: 3019HTML: 181 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1565PDF: 697HTML: 446 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1525PDF: 1031HTML: 95 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1318PDF: 782HTML: 3100 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2491PDF: 1562HTML: 2333Table1: 172 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1221PDF: 586HTML: 3051 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2043PDF: 1916HTML: 137 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2305PDF: 957HTML: 1626Fig 1: 163Tab I: 190Cover Letter: 179 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3638PDF: 1404HTML: 455Figures . Eliassian: 198 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1189PDF: 449HTML: 18539Figure 1: 151Figure 2: 132Figure 3: 152Figure 4: 185Figure 5: 153 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
962PDF: 883Suppl. Files: 576HTML: 70 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1466PDF: 860HTML: 1928Figure: 148Tables: 164ALL revision 1: 172response to reviewer: 158 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3362PDF: 1441HTML: 63 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1858PDF: 1321HTML: 244 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1077PDF: 578HTML: 6780 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
1938PDF: 770HTML: 194 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2122PDF: 763HTML: 1603Figure 1: 159Table 1: 184 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1223PDF: 523Suppl. Files: 322HTML: 127 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1152PDF: 437HTML: 129 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1467PDF: 555HTML: 167 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2011PDF: 958HTML: 4045Cover Letter: 204Figure 1: 200Figure 2: 209Table 1: 184 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1751PDF: 686HTML: 2082Untitled: 186Untitled: 137Untitled: 151Untitled: 137Untitled: 144Untitled: 160Untitled: 166







